Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.330
-0.060 (-4.32%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $6.1 million as of July 23, 2026. Its market cap has decreased by -20.08% in one year.
Market Cap
6.10M
Enterprise Value
-407.41K
1-Year Change
-20.08%
Ranking
Category
Stock Price
$1.33
ChartMarket Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $6.10M, an increase of 22.70%. That is a compound annual growth rate of 1.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 6.10M | -12.81% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 6.58M |
| Acurx Pharmaceuticals | 6.49M |
| XTL Biopharmaceuticals | 6.47M |
| BioAtla | 6.44M |
| Cadrenal Therapeutics | 6.18M |
| Processa Pharmaceuticals | 6.13M |
| Pulmatrix | 6.06M |
| Addex Therapeutics | 5.92M |